Severity, control and treatment of a cohort of aspirin-sensitive asthmatics (ASA)

G. Bochenek, J. Kuschill-Dziurda, D. Dziurda, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland)

Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Session: Asthma assessment and original therapeutic approaches
Session type: E-Communication Session
Number: 4564
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Bochenek, J. Kuschill-Dziurda, D. Dziurda, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland). Severity, control and treatment of a cohort of aspirin-sensitive asthmatics (ASA). Eur Respir J 2009; 34: Suppl. 53, 4564

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials
Source: International Congress 2016 – Asthma management
Year: 2016


Effects of Omalizumab treatment on nasal symptoms (SNOT score) in patients treated for severe asthma.
Source: International Congress 2017 – Asthma management
Year: 2017

Symptom profile in obese asthmatics compared with non obese asthmatics in stable state
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013

Asthma control test (ACT) in outpatients and hospitalized patients with bronchial asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


Endoscopic sinus surgery (ESS) attenuates aspirin-induced asthmatic reaction in patients with aspirin-intolerant asthma (AIA)
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Year: 2007


Efficacy of omalizumab in patients with moderate-to-severe allergic asthma that is poorly controlled on GINA (1998) treatment step 3 or 4
Source: Eur Respir J 2003; 22: Suppl. 45, 203s
Year: 2003

Eicosanoid concentrations in induced sputum (IS) in stable asthmatics with aspirin-tolerant (ATA) and aspirin-intolerant asthma (AIA)
Source: Eur Respir J 2005; 26: Suppl. 49, 575s
Year: 2005

Is the asthma control questionnaire (ACQ) usefull during acute moderate to severe (AMS) asthma exacerbations (AE)?
Source: Eur Respir J 2004; 24: Suppl. 48, 591s
Year: 2004

Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

The elderly subjects with asthma (ELSA) study. Asthma in subjects ≥65 yrs and its overlap with COPD
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013

Clinical experience with montelukast plus ICS vs. only ICS in non-asthmatic eosinophilic bronchitis (NAEB) in Indian patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT)
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012


A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010


Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009

Applicability of the asthma control test (ACT) in elderly asthmatics
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008


Omalizumab (Xolair®) reduces exacerbations in adolescents more than in adults with allergic (IgE-mediated) asthma: a subgroup analysis of pooled clinical trials
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Severity of allergic rhinitis and asthma control
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010


Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014

Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Asthma control test (ACT) scores among asthmatics regularly attending outpatients
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007